A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.
Neuropeutics is collaborating with LifeArc on a small molecule therapy that reportedly lowered TDP-43 clumping in an animal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback